DiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPsychiatry and PsychologyPhenomena and ProcessesDisciplines and OccupationsAnthropology, Education, Sociology and Social PhenomenaTechnology, Industry, AgricultureHumanitiesInformation ScienceNamed GroupsHealth CareGeographicals
Clinical Trials as TopicClinical Trials, Phase III as TopicDouble-Blind MethodResearch DesignClinical Trials, Phase II as TopicClinical Trials, Phase I as TopicControlled Clinical Trials as TopicTreatment OutcomePlacebosTime FactorsClinical ProtocolsFollow-Up StudiesPatient SelectionEarly Termination of Clinical TrialsSingle-Blind MethodProspective StudiesMulticenter Studies as TopicClinical Trials Data Monitoring CommitteesDrug Administration ScheduleDrug Therapy, CombinationSample SizeQuality of LifeCost-Benefit AnalysisAntineoplastic Combined Chemotherapy ProtocolsPilot ProjectsClinical Trials, Phase IV as TopicOutcome Assessment (Health Care)NeoplasmsAntineoplastic AgentsCombined Modality TherapySurvival AnalysisPatient ComplianceAdministration, OralSeverity of Illness IndexRecurrenceCross-Over StudiesIntention to Treat AnalysisEvidence-Based MedicineRisk FactorsDose-Response Relationship, DrugDietary SupplementsQuestionnairesDisease-Free SurvivalFeasibility StudiesExercise TherapyRandom AllocationResearch SubjectsSurvival RateUnited StatesPain MeasurementCognitive TherapyTrial of LaborRisk AssessmentPlacebo EffectInfusions, IntravenousBreast NeoplasmsStrokePrognosisPatient Education as TopicDrug EvaluationMeta-Analysis as TopicData Interpretation, StatisticalPatient SatisfactionDisease ProgressionInformed ConsentDrug CombinationsKaplan-Meier EstimateReproducibility of ResultsAnalysis of VariancePatient ParticipationChemotherapy, AdjuvantTreatment FailurePatient DropoutsGreat BritainAcute DiseaseLung NeoplasmsBias (Epidemiology)PregnancyChronic DiseaseTherapeutic Human ExperimentationPublishingHIV InfectionsFluorouracilCounselingPainExerciseMyocardial InfarctionAntibodies, Monoclonal, HumanizedBiomedical ResearchPaclitaxelInfant, NewbornCluster AnalysisProportional Hazards ModelsAntibodies, MonoclonalNeoplasm StagingCisplatinDrugs, InvestigationalRisk Reduction BehaviorBiological MarkersPublication Bias